🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Arbutus Biopharma Corporation

ABUS Healthcare
$5.2 $-0.01 (-0.19%)
Market Cap: $1.03 B
Gurus Holding
2
Popularity Rank
#3485
% of Shares Held
0.88%
Net Activity (Q2 2026)
-$915,415.14

Guru Ownership Trend

Guru Analysis for Arbutus Biopharma Corporation (ABUS)

Arbutus Biopharma Corporation (ABUS), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $9.07 M.

Top institutional holders include Jefferies Group and Cliff Asness.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $915,415.14 net outflow during the quarter.

Recent activity highlights Cliff Asness who increased their stake by 33.3%. Conversely, Jefferies Group reduced exposure by 9.6%.

Key Holders

Top 5 by Value

$8.22 M
$152,358

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$38,025.9
Total Buy Value
New Buys 0
Additions 1
-$953,441.04
Total Sell Value
Reductions 1
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
2
Net Buyers
1

FAQs for Arbutus Biopharma Corporation (ABUS)

Major holders include Jefferies Group ($8.22 M), Cliff Asness ($152,358). According to the latest reported data, 2 tracked investment managers collectively hold approximately 1.74 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $915,415.14, with 1 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited ABUS. The total reported sell value was $953,441.04.

Yes, 0 managers opened new positions in ABUS, and 1 increased their existing holdings. The total reported buy value was $38,025.9.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.05% Reduce -9.6% 1,711,672 $8.22 M Q2 2026
0.00% Add 33.3% 31,741 $152,358 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form